Medical Cleanroom Industry Articles

Epson Robots Introduces GX Series SCARA Robots to Deliver Next-Level Performance and Flexibility

Engineered to meet unique automation needs across various industries, Epson Robots, the #1 SCARA robot manufacturer in the world, today announced the new GX Series robot lineup with the GX4 and GX8.

Biomerics Announces  ISO 13485 Cleanroom Expansion in Ireland

The new Biomerics office will be equipped with multiple balloon-forming machines, state-of-the-art test equipment, and a cleanroom that is ISO 13485:2016 certified.

Amcor to expand healthcare packaging cleanrooms in Ireland

Through this investment, the Sligo site will feature Class 7 cleanroom manufacturing environments and state-of-the art thermoforming operations, fully certified to ISO 13485 standards and meeting the highest regulatory requirements.

Celerion Expands Early Phase Clinical Pharmacology Units

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services

Zeus Invests in Global Expansion to Increase Catheter Manufacturing Capacity

Zeus Invests in Global Expansion to Increase Catheter Manufacturing Capacity

Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide

SK pharmteco Announces $35m Investment in Phase 1 of New Pharmaceutical Manufacturing Plant

SK pharmteco Announces $35m Investment in Phase 1 of New Pharmaceutical Manufacturing Plant

SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.

Pfizer to invest $120M at Kalamazoo facility for COVID-19 antiviral treatment

Pfizer to invest $120M at Kalamazoo facility for COVID-19 antiviral treatment

Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.

Precision Coating Announces Merger with N2 Biomedical to Expand Medical Device Coating Platform

Precision Coating Announces Merger with N2 Biomedical to Expand Medical Device Coating Platform

Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company.

read more
Olympus ViziShot 2 FLEX 19 G EBUS-TBNA Needle Helps Guide Lung Cancer Treatment

Olympus ViziShot 2 FLEX 19 G EBUS-TBNA Needle Helps Guide Lung Cancer Treatment

Olympus announced today the results of a pilot study showing the safety and effectiveness of the ViziShot 2 FLEX 19 G EBUS-TBNA Needle in gathering tissue samples critical to guiding treatment of non-small cell lung cancer (NSCLC).

read more
Spectrum Plastics Group Announces Building Renovation & Cleanroom Expansion at Minneapolis Facility

Spectrum Plastics Group Announces Building Renovation & Cleanroom Expansion at Minneapolis Facility

Spectrum Plastics Group, a global solutions provider for development through scaled manufacturing of critical polymer-based components and devices for medical and other demanding markets, is excited to announce a significant renovation and cleanroom expansion project at its Minneapolis, MN facility.

read more
Signature Biologics™ Opens Expanded Manufacturing and R&D Headquarters in Irving, TX

Signature Biologics™ Opens Expanded Manufacturing and R&D Headquarters in Irving, TX

Signature Biologics, LLC., today announced their expanded operations footprint to include a new 36,000 sq ft facility in Irving, TX. This newly constructed space mirrors Signature Biologics’ transparency in doing business with open floor plan and floor-to-ceiling views into its fully equipped manufacturing and R&D laboratory spaces.

read more
Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

Artiva Biotherapeutics, an oncology company specializing in primary allogeneic natural killer (NK) cell therapies to treat cancer, announced on Aug. 12, 2021 an expansion of its US presence with a new R&D and GMP manufacturing facility in San Diego, Calif., for cell therapies.

read more